Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda R Gowing

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|October 6, 2012
The role of opioid substitution treatment in reducing HIV transmissionLinda R Gowing
Evidence-Based Mental Health|April 27, 2004
Office based treatment with buprenorphine plus naloxone, or buprenorphine alone reduces opiate use and cravingLinda R Gowing, Olga Lopatko
Drug and Alcohol Review|September 17, 2004
Pharmacotherapies for problematic psychostimulant use: a review of current researchJames Shearer, Linda R Gowing
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 20, 2012
Supplementary thiamine is still important in alcohol dependenceEllen Rees, Linda R Gowing
Addiction (Abingdon, England)|July 15, 2015
Reply to Warnakulasuriya et alLinda R Gowing, Robert West
Current Opinion in Psychiatry|April 14, 2006
The place of detoxification in treatment of opioid dependenceLinda R Gowing, Robert L Ali
Bulletin of the World Health Organization|April 5, 2013
Mitigating the risk of HIV infection with opioid substitution treatmentLinda R Gowing, Matthew Hickman, Louisa Degenhardt
The Medical Journal of Australia|June 18, 2002
Which substitution pharmacotherapy is most effective in treating opioid dependence?Linda R Gowing, Robert L Ali, Jason M White
Addiction (Abingdon, England)|March 16, 2002
Alpha2-adrenergic agonists in opioid withdrawalLinda R Gowing, Michael Farrell, Robert L Ali, et al.
Journal of General Internal Medicine|December 13, 2005
Brief report: Methadone treatment of injecting opioid users for prevention of HIV infectionLinda R Gowing, Michael Farrell, Reinhard Bornemann, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|October 6, 2012
The role of opioid substitution treatment in reducing HIV transmissionLinda R Gowing
Evidence-Based Mental Health|April 27, 2004
Office based treatment with buprenorphine plus naloxone, or buprenorphine alone reduces opiate use and cravingLinda R Gowing, Olga Lopatko
Drug and Alcohol Review|September 17, 2004
Pharmacotherapies for problematic psychostimulant use: a review of current researchJames Shearer, Linda R Gowing
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 20, 2012
Supplementary thiamine is still important in alcohol dependenceEllen Rees, Linda R Gowing
Addiction (Abingdon, England)|July 15, 2015
Reply to Warnakulasuriya et alLinda R Gowing, Robert West
Current Opinion in Psychiatry|April 14, 2006
The place of detoxification in treatment of opioid dependenceLinda R Gowing, Robert L Ali
Bulletin of the World Health Organization|April 5, 2013
Mitigating the risk of HIV infection with opioid substitution treatmentLinda R Gowing, Matthew Hickman, Louisa Degenhardt
The Medical Journal of Australia|June 18, 2002
Which substitution pharmacotherapy is most effective in treating opioid dependence?Linda R Gowing, Robert L Ali, Jason M White
Addiction (Abingdon, England)|March 16, 2002
Alpha2-adrenergic agonists in opioid withdrawalLinda R Gowing, Michael Farrell, Robert L Ali, et al.
Journal of General Internal Medicine|December 13, 2005
Brief report: Methadone treatment of injecting opioid users for prevention of HIV infectionLinda R Gowing, Michael Farrell, Reinhard Bornemann, et al.
Pageof 2